Innate Pharma
IPHA
#8351
Rank
ยฃ0.12 B
Marketcap
ยฃ1.49
Share price
0.00%
Change (1 day)
-23.61%
Change (1 year)

Revenue for Innate Pharma (IPHA)

Revenue in 2023: ยฃ43.08 Million

According to Innate Pharma 's latest financial reports the company's current revenue (TTM ) is ยฃ43.08 Million. In 2023 the company made a revenue of ยฃ43.08 Million an increase over the revenue in the year 2022 that were of ยฃ39.93 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innate Pharma from 2005 to 2023

Annual revenue

Year Revenue Change
2023ยฃ43.08 M7.88%
2022ยฃ39.93 M287.78%
2021ยฃ10.29 M-80.14%
2020ยฃ51.87 M-10.13%
2019ยฃ57.71 M-15.91%
2018ยฃ68.63 M133.44%
2017ยฃ29.4 M-33.72%
2016ยฃ44.36 M201.72%
2015ยฃ14.7 M1674.86%
2014ยฃ0.82 M-93.59%
2013ยฃ12.93 M25.45%
2012ยฃ10.3 M41.8%
2011ยฃ7.26 M68.46%
2010ยฃ4.31 M-48.02%
2009ยฃ8.3 M-38.81%
2008ยฃ13.56 M-13.41%
2007ยฃ15.66 M86.54%
2006ยฃ8.4 M286.35%
2005ยฃ2.17 M